Introduction
Nowadays, there are a number of light-assisted treatments for medical application, such as UV-B treatment for psoriasis, red light for acne vulgaris, daylight spectrum for seasonal affected disorder, Levulan blue light for skin psoriasis or jaundice, and GreenLight Laser PVP (Photoselective Vaporization of the Prostate) for benign prostatic hyperplasia. However, there have been problems noted with light treatments; for example, Valejo Coelho and Apetato [1] did a study on adverse effects of phototherapy which could lead to certain skin cancers. In addition, other studies from Wickremasinghe et al. [2] and Frazier et al. [3] have noted a significant increased risk of cancer in infants after neonatal phototherapy.
There are 143 well-known hereditary cancer predisposition genes ( Table 1 ) that have been documented for genetic analysis. The mutation of these genes serves as markers of cancer cells after pathological and biopsy analysis. Therefore, the question arises; if any patients who have been previously diagnosed with mutation of such genes need phototherapy or light-assisted treatments, will there be any effect on these mutant gene expression levels? As a number of wavelengths have been used, how certain wavelengths affect the whole genes and their expression has not been clarified.
This study aimed to evaluate the changes of expression levels of cancer predisposition genes after irradiation with red (635 nm), green (520 nm), and blue (465 nm) LED light by using microarray and cell culture techniques.
Materials and Methods

LED Light
Source. An apparatus equipped with blue (465 nm), green (520 nm), and red (635 nm) light emitting diodes with a 1 ampere power supply was constructed for this experiment. Calibrating analysis of the light's emission spectra and power was provided by a monochrome meter and a power meter from the Department of Physics, Prince of Songkla University. The LED diode array (15 cm by 15 cm), assembled by a technician from the Department of Electrical Engineering, Prince of Songkla University, consisted of three different wavelength array panels that could be placed over and perfectly cover a 10 cm cell culture plate. In this array, the AIP  APC  BAP1  BRCA2  AKT1  ASCC1  BARD1  BRIP1  ALK  ATM  BLM  BUB1B  ANTXR1  ATR  BMPR1A  CD96  ANTXR2  AXIN2  BRCA1  CDC73  CDH1  FANCI  MUTYH  RUNX1  CDK4  FANCL  NBN  SBDS  CDKN1B  FANCM  NDUFA13  SDHA  CDKN2A  FH  NF1  SDHAF2  CHEK1  FLCN  NF2  SDHB  CHEK2  GALNT12  NTRK1  SDHC  CYLD  GATA2  PALB2  SDHD  CYP21A2  GL13  PALLD  SLX4  DDB2  GLMN  PDE11A  SMAD4  DICER1  GPC3  PDGFRA  SMARCA4  DIS3L2  HFE  PIK3CA  SMARCB1  DKC1  HRAS  PMS2  STK11  EHBP1  KDR  POLD1  SUFU  EPCAM  KIF1B  POLE  TERT  EPHB2  KIT  POLH  TGFBR1  ERCC2  KLHDC8B  POU6F2  TINF2  ERCC3  LIG4  PRKAR1A  TMC6  ERCC4  LYST  PTCH1  TMC8  ERCC5  MAX  PTCH2  TMEM127  ERCC6  MC1R  PTEN  TP53  ESCO2  MEN1  RAD50  TSC1  EXT1  MET  RAD51B  TSC2  EXT2  MITE  RAD51C  UROD  FAH  MLH1  RAD51D  VHL  FANCA  MLH3  RB1  WAS  FANCB  MRE11A  RECQL4  WRN  FANCC  MSH2  RET  WT1  FANCD2  MSH6  RHBDF2  XPA  FANCE  MSMB  RNASEL  XPC  FANCF  MSR1  RSPO1  XRCC3  FANCG  MTAP  RTEL1 blue LED emitted light between 440 and 500 nm with peak emission at 465 nm, the green LED emitted light between 495 and 575 nm with peak emission at 520 nm, and the red LED emitted light between 610 and 660 nm with peak emission at 635 nm.
Cell Culture Assay.
Both the type 2 diabetic fibroblast cell line from a donor diagnosed with type II diabetes (untransformed, Caucasian, MODY, aged 23 years, Cat. #AG06083) and healthy normal fibroblast cell line (male, leg skin, untransformed, Caucasian, Cat. #GM03440) were obtained from the Coriell Institute for Medical Research and cultured at 37 ∘ C 5% CO 2 in DMEM (supplemented with 10% FBS and 100 g/ml streptomycin Penn Strep) from GIBCO in 10 cm plates with 2,000,000 cells of initial seeding density.
During the entire experiment, these cells were maintained and used in not more than five passages. The type 2 diabetic fibroblast cell line and healthy normal fibroblast cell line were cultured at the regular normal glucose level under the assumption that they were from glycemic well-controlled patients. The type 2 diabetic fibroblast cell line and healthy normal fibroblast cell line served as treated groups and control groups, respectively.
LED Irradiation
Assay and mRNA Isolation. Before LEDlight exposure, the cells were cultured until 90% confluence and a number of artificial wounds were randomly created with a 1 ml plastic pipette tip in order to reduce bias of the result and simulate the real wounded shape. Then, in the treatment groups, 3 groups each of diabetic fibroblasts and normal fibroblast cells were exposed to the light at 0.67 J/cm 2 for 10 minutes at different wavelengths. According to our preliminary experiment, the light irradiating energy at 0.67 J/cm 2 was the optimum level for this in vitro experiment. One of the diabetic fibroblasts and one healthy normal fibroblast received no light exposure to serve as controls. The details of the treated groups are shown in Table 2 . The energy power of the light that the cells received was carefully calibrated by an optical power meter. The irradiation distance from the LED diode array to the media surface was 10 cm. The apparatus had been placed in a laminar flow (ESCO class II), and a cooling airflow fan constantly maintained a constant temperature during the light exposure. After that, all cells were suddenly trypsinized and their mRNA extracted. All extractions were performed with a GeneJet RNA purification kit from Thermo Scientific. Each condition was pentaplicated for reliable and valid results.
mRNA Microarray
Assay. All mRNA samples were shipped to a certified Agilent microarray service in India and the purity of the mRNA samples was tested by Bioanalyzer with an RNA integrity number (RIN) higher than 8.0 before carrying on to hybridize with the microarray chips. SurePrint G3 human gene expression 8x60k V2 chips were used for this experiment.
Statistical and Microarray Data Analysis.
All raw data were analyzed by GeneSpring 13. All gene expression profiles with a 2-fold or greater difference were selected and followed by differential gene expression analysis (fold change analysis), gene ontology analysis, and pathway analysis. For differential gene expression analysis (fold change analysis), it was calculated by the absolute ratio of normalized intensities (no log scale) between the average intensities of the samples grouped. For gene ontology (GO) analysis, it was an analysis to observe how significantly such genes can affect certain function of a cell. This analysis was calculated by using Benjamini-Yekutieli procedure with corrected values. Finally, for pathway analysis, curated pathways from the WikiPathways.org were imported to GeneSpring 13 software in order to visualize every pathway that such genes had been affected. The cutoff level for all analyses was a value less than 0.05. The raw 
Results
Differential Gene Expression.
After the mRNA samples of the fibroblast cells were analyzed by GeneSpring 13, all results were categorized and compared as shown in Figures  1 and 2 . Total gene expression profiles and raw data can be accessed through the GEO database of the NCBI at GSE78017 and GSE78018. Only 143 predisposition cancer genes were selected and further analyzed, comparing them with untreated normal human fibroblasts (control group). Figure 1 shows 37 genes from normal human fibroblast cells of each treatment group which were significantly 2-fold or more up or down ( < 0.05). In the NCL blue group, BUB1B, MSR1, FANCD2, and ERCC5 were significantly upregulated, while DKC1, HFE, MSR1, FLCN, MSH6, CD96, RAD51B, ERCC5, and TP53 genes were significantly downregulated. In the NCL green group, the EPHB2, KIT, ANTXR2, ESCO2, MSR1, EXT1, TSC1, BUB1B, EPCAM, FANCD2, NF1, DIS3L2, and RET genes were significantly expressed at higher levels, while 6 genes, DKC1, ERCC5, GPC3, MSH6, PDE11A, and TP53, showed significantly lower expression. In the NCL red group, FANCB, POLH, KIT, POLE, BUB1B, DIS3L2, FANCD2, SUFU, TMC8, MSR1, and RET had significantly high expression, while NF1, NTRK1, MSR1, ANTXR1, ERCC5, FLCN, and TP53 were expressed at significantly lower levels. Figure 2 shows 54 genes from diabetic human fibroblast cells of each treatment group which were significantly overor downexpressed 2-fold or more ( < 0.05). In the DMCL blue group, RUNX1, FANCD2, BMPR1A, BUB1B, EPHB2, EHBP1, PDE11A, RET, and KDR were significantly upregulated, while NF1, KIT, GALNT12, TMC6, ERCC5, DKC1, and TP53 were significantly downregulated. In the DMCL green group, only EPHB2, SDHC, and NF1 genes were significantly expressed at higher levels, while 12 genes, CD96, PTCH2, AXIN2, NF1, EPCAM, MSH6, GALNT12, ERCC5, KIT, NF1, DKC1, and TP53, had significantly lower expression. And in the DMCL red group, RUNX1, PDGFRA, EHBP1, GPC3, AXIN2, KDR, GLMN, MSMB, EPHB2, MSR1, and KIT had significantly high expression, and 5 genes, GPC3, TMC6, PTCH1, DKC1, and TP53 genes, were expressed at significantly lower levels.
Gene Ontology Analysis of the Blue Light Irradiation
Group. For the groups which were irradiated with blue light and compared with NCL, only 4 genes, BUB1B, MSR1, FANCD2, and ERCC5, were upregulated after blue light irradiation in normal fibroblast cells. However, there were no significant changes to gene ontology. In contrast, 9 genes were detected with significantly lower expression, DKC, HFE, MSR, FLCN, MSH6, CD96, RAD51B, ERCC5, and TP53. These suppressed genes are known to have a direct impact on lowering DNA repair activity during the replication fork process.
In addition, in the DMCL blue group, the 9 genes shown in Table 3 (RUNX1, FANCD2, BMPR1A, BUB1B, EPHB2, EHBP1, PDE11A, RET, and KDR) were highly activated and all of them can significantly affect embryonic hemopoiesis, transferase activities, and protein phosphorylation. On the other hand, 7 genes were clearly observed to have lower expression, NF, KIT, GALNT12, TMC6, ERCC5, DKC, and TP53. These genes were significantly downregulated, and downregulation of these genes has a negative effect on the regulation of neuroblast proliferation.
Gene Ontology Analysis of Green Light Irradiation.
Sixteen genes were upregulated in the NCL green group after green light irradiation in normal fibroblast cells. This set of genes could significantly affect transmembrane receptor protein tyrosine kinase activities. In contrast, 6 genes (DKC1, ERCC5, GPC3, MSH6, PDE11A, and TP53) were detected with significantly lower expression (Table 3) . These suppressed genes directly affected structure-specific DNA secondary structure binding for DNA repair, replication, and DNA metabolic process.
In addition, in the DMCL green group, only 3 genes, EPHB2, SDHC, and NF, were highly activated; all of these genes are significantly involved in the regulation of neuronal synaptic plasticity. On the other hand, the other 12 genes, CD96, PTCH2, AXIN2, NF1, EPCAM, MSH6, GALNT12, ERCC5, KIT, NF1, DKC1, and TP53, had lower expression (Table 3) . These 12 genes were significantly downregulated which affected the cellular immune response, DNA metabolic process, the negative regulation of neuroblast proliferation, response to light stimulus, epithelium development, and maintenance of DNA repeat elements.
Gene Ontology Analysis of Red Light Irradiation.
In the NCL red group in which the cell lines were irradiated with red light and compared with NCL, there were no significant positive changes to gene ontology (12 genes, Table 3 ). In contrast, 7 genes, NF1, NTRK1, MSR1, ANTXR1, ERCC5, FLCN, and TP53, showed significantly lower expression. These suppressed genes are known to have a direct impact on RAS protein signal transduction, the negative regulation of neuroblast proliferation, sympathetic nervous system development, and the positive regulation of adenylate cyclase activities.
In addition, in the DMCL red group, 12 genes (RUNX1, PDGFRA, EHBP1, GPC3, AXIN2, KDR, GLMN, MSMB, EPHB2, MSR1, and KIT, Table 3 ) were upregulated in normal BUB1B  FANCD2  EPHB2  BUB1B  FANCB  FANCD2  MSR1  ERCC5  KIT  EPCAM  POLH  SUFU  ANTXR2  FANCD2  KIT  TMC8  ESCO2  NF1  POLE  MSR1  MSR1  DIS3L2  BUB1B  RET  EXT1  RET  DIS3L2  TSC1   Down   DKC1  CD96  DKC1  MSH6  NF1  ERCC5  HFE  RAD51B  ERCC5  PDE11A  NTRK1  FLCN  MSR1  ERCC5  GPC3  TP53  MSR1  TP53  FLCN  TP53  ANTXR1  MSH6   DMCL   Up   RUNX1  PDE11A  EPHB2  RUNX1  GLMN  FANCD2  RET  SDHC  PDGFRA  MSMB  BMPR1A  KDR  NF1  EHBP1  EPHB2  BUB1B  GPC3  MSR1  EPHB2  AXIN2  KIT  EHBP1  KDR   Down   NF1  ERCC5  CD96  GALNT12  GPC3  DKC1  KIT  DKC1  PTCH2  ERCC5  TMC6  TP53  GALNT12  TP53  AXIN2  KIT  PTCH1  TMC6  NF1  NF1  EPCAM  DKC1  MSH6  TP53 fibroblast cells. These highly active genes directly affected protein kinase activities, vascular endothelial growth factor binding, ovarian follicle development, and hematopoietic progenitor cell differentiation (immune system development). On the other hand, only 5 genes in this group were clearly observed to have lower expression, GPC3, TMC6, PTCH1, DKC1, and TP53. This set of genes is known to have a direct effect on the process of cell proliferation involved in metanephros development of the kidney.
Discussion
We found that phototherapy can significantly affect the expression of certain brain, lung, breast, ovarian, and prostate cancer "predisposition genes" in nondiabetic patients and also increase the risk of juvenile intestinal polyposis, hemangioma, multiple endocrine neoplasia, endometrial cancer, and chronic myeloid leukemia in diabetic patients. Green light irradiation may significantly increase the chances for a number of cancers in nondiabetic patients (Table 4 ). For example, irradiated patients are at increased risk of developing hyaline fibromatosis, neurofibromatosis, brain cancer, lung cancer, prostate cancer, breast cancer, Wilms tumor, multiple endocrine neoplasia, Barrett's esophagus/esophageal adenocarcinoma, and endometrial cancer in patients with an existing gastrointestinal stromal tumor. In contrast, the green light irradiation could develop only a few types of cancers, such as brain cancer, prostate cancer, neurofibromatosis, and paragangliomas in diabetic patients (Table 5) . Thus, patients who require prostate surgery with a green light laser should be carefully checked to see whether they have mutated predisposition genes before their surgery. In addition, using excessive blue light for skin psoriasis and jaundice treatment may increase the occurrences of particular cancers in newborns who have been genetically diagnosed with these mutated genes.
For red light irradiation, prostate cancer, breast cancer, brain cancer, lung cancer, Wilms' tumor, Fanconi anemia, Barrett's esophagus/esophageal adenocarcinoma, xeroderma pigmentosum, medulloblastoma, epidermodysplasia verruciformis, colorectal cancer, and endometrial cancer in gastrointestinal stromal tumor could develop in nondiabetic patients (Table 4) . On the other hand, for diabetic patients considered for red light irradiation, the high expression of such genes may increase the rates of colorectal cancer, prostate cancer, Barrett's esophagus/esophageal adenocarcinoma, glomangioma, Wilms' tumor, hemangioma, and myeloid malignancy (Table 5) . Hence, a red light phototherapy for acne vulgaris and other cosmetic purposes could be a potential threat that the doctors and diabetic patients should be aware of. 7 Table 4 : Cancer-related predisposition genes that were overexpressed after blue, green, or red light irradiation in normal healthy fibroblast cells (nondiabetic patients) ( < 0.05). In short, according to the results of this experiment, any wavelength can either increase or lower expression of particular mutated predisposition cancer genes. Therefore, awareness of potential side effects should be considered before any proposed laser operation. In addition, one can take advantage of this phototherapy to either be aware of the side effects on how light can induce the expression of certain predisposition cancer genes or suppress certain mutated genes to reduce causes of cancers. In contrast, one may take advantage of how phototherapy downregulates or suppresses the expression of certain predisposition genes which may reduce the progression of cancer cells to develop further. For example, the expression of mutated TP53 gene, a cancer marker gene causing Li-Fraumeni syndrome, breast cancer, soft tissue sarcoma, osteosarcoma (bone cancer), leukemia, brain tumors, and adrenocortical carcinoma, can be reduced by irradiating with blue, green, or red light. In addition, both ERCC5 and TP53 genes were found with significantly lower expression in all treated groups. These genes work as tumor suppressor genes; therefore, intense phototherapy could definitely decrease the DNA repair function. Moreover, lower expression of DKC1 was also found, which is important as DKC1 is able to control the length of telomerases after the cell cycle. Eventually, either more abnormal cells would be produced or more apoptosis could occur. These hypotheses are supported by previous studies from Płonka et al. [4] and Acedo and Zawacka-Pankau [5] . These studies found that the expression of the P53 (also called TP53) gene was lower after phototherapy, which led to the initiation of the apoptosis process.
Light condition
In addition, for patients with neurofibromatosis type 1 (a mutated NF1 gene), intense pulsed-radio frequency (IPL-RF) in combination with topical application of vitamin D3 ointment is one of the current treatments. What if we use red light to suppress the expression of this mutated NF1? Could it improve the quality of their lives? Our study suggests that red light irradiation could significantly reduce the expression of the NF1 gene in nondiabetic patients and blue light irradiation significantly lowers the expression of NF1 gene in diabetic patients.
Therefore, gene screening for these 143 predisposition genes should be implemented before any phototherapy treatment and further investigations are strongly recommended to explore the benefits of phototherapy for cancer treatment.
Conclusion
Phototherapy increases the expression of cancer predisposing genes in both normal and diabetic cell lines. Green light activates EPHB2, KIT, ANTXR2, ESCO2, MSR1, EXT1, TSC1, KIT, NF1, BUB1B, FANCD2, EPCAM, FANCD2, NF, DIS3L2, and RET in normal fibroblast cells, whereas blue and red light can upregulate RUNX1, PDGFRA, EHBP1, GPC3, AXIN2, KDR, GLMN, MSMB, EPHB2, MSR1, KIT, FANCD2, BMPR1A, BUB1B, PDE11A, and RET. Genetic screening before applying phototherapy may be warranted.
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